Chronic suppression of-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats

International Journal of Obesity

Volumn 34, Issue 6, 2010, Pages 1001-1010

  Lenard, N R ^a   Zheng, H ^a   Berthoud, H R ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Body weight; Fat mass; Hedonics; High fat chow; Nucleus accumbens core and shell; Reward

Indexed keywords

BETA FUNALTREXAMINE; CARPROFEN; MU OPIATE RECEPTOR; BETA-FUNALTREXAMINE; DRUG DERIVATIVE; ENSURE; NALTREXONE; NARCOTIC ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; HYPOTHESIS; LIPID DIET; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WEIGHT GAIN; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ELEMENTAL DIET; FAT INTAKE; FOOD PREFERENCE; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT; SUGAR INTAKE;

RATTUS;

ANIMALS; BODY WEIGHT; DIETARY FATS; DIETARY SUCROSE; FOOD PREFERENCES; FOOD, FORMULATED; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 77953614830     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.297     Document Type: Article

References (56)

1. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 2003; 299: 853-855.
2. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006; 331: 166-174.
3. Weinsier RL, Hunter GR, Heini AF, Goran MI, Sell SM. The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity. Am J Med 1998; 105: 145-150.
4. O'Rahilly S, Farooqi IS. Genetics of obesity. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1095-1105.
5. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095. (Pubitemid 36337319)
6. Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 2002; 22: 3306-3311.
7. Lutter M, Nestler EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr 2009; 139: 629-632.
8. Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 2008; 32: 20-39.
9. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci 2005; 8: 555-560.
10. Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3191-3200.
11. Rogers PJ, Smit HJ. Food craving and food 'addiction': a critical review of the evidence from a biopsychosocial perspective. Pharmacol Biochem Behav 2000; 66: 3-14.
12. Saper CB, Chou TC, Elmquist JK. The need to feed: homeostatic and hedonic control of eating. Neuron 2002; 36: 199-211.
13. Berthoud HR, Morrison C. The brain, appetite, and obesity. Annu Rev Psychol 2008; 59: 55-92.
14. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 2002; 76: 365-377.
15. Kelley AE, Bless EP, Swanson CJ. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J Pharmacol Exp Ther 1996; 278: 1499-1507.
16. Will MJ, Franzblau EB, Kelley AE. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 2003; 23: 2882-2888.
17. Zheng H, Patterson LM, Berthoud HR. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci 2007; 27: 11075-11082.
18. Zhang M, Gosnell BA, Kelley AE. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 1998; 285: 908-914.
19. Zheng H, Patterson LM, Berthoud HR. Orexin-signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci 2007; 27: 11075-11082.
20. Zheng H, Corkern M, Stoyanova I, Patterson LM, Tian R, Berthoud HR. Peptides that regulate food intake: appetite-inducing accumbens manipulation activates hypothalamic orex-in neurons and inhibits POMC neurons. Am J Physiol Regul Integr Comp Physiol 2003; 284: R1436-R1444.
21. Groenewegen HJ, Russchen FT. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochem-ical study in the cat. J Comp Neurol 1984; 223: 347-367.
22. Otake K, Nakamura Y. Possible pathways through which neurons of the shell of the nucleus accumbens influence the outflow of the core of the nucleus accumbens. Brain Dev 2000; 22 (Suppl 1): S17-S26.
23. Sano H, Yokoi M. Striatal medium spiny neurons terminate in a distinct region in the lateral hypothalamic area and do not directly innervate orexin/hypocretin-or melanin-concentrating hormone-containing neurons. J Neurosci 2007; 27: 6948-6955.
24. Usuda I, Tanaka K, Chiba T. Efferent projections of the nucleus accumbens in the rat with special reference to subdivision of the nucleus: biotinylated dextran amine study. Brain Res 1998; 797: 73-93.
25. Portoghese PS, Larson DL, Sayre LM, Fries DS, Takemori AE. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J Med Chem 1980; 23: 233-234.
26. Ward SJ, Portoghese PS, Takemori AE. Improved assays for the assessment of kappa-and delta-properties of opioid ligands. Eur J Pharmacol 1982; 85: 163-170.
27. Ward HG, Nicklous DM, Aloyo VJ, Simansky KJ. Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating. Eur J Neurosci 2006; 23: 1605-1613.
28. Ward HG, Simansky KJ. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food. Psychopharmacology (Berl) 2006; 187: 435-446.
29. Arjune D, Standifer KM, Pasternak GW, Bodnar RJ. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res 1990; 535: 101-109.
30. Cole JL, Leventhal L, Pasternak GW, Bowen WD, Bodnar RJ. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res 1995; 678: 168-176.
31. Cole JL, Berman N, Bodnar RJ. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats. Peptides 1997; 18: 1201-1207.
32. Bodnar RJ, Glass MJ, Ragnauth A, Cooper ML. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res 1995; 700: 205-212.
33. Ragnauth A, Moroz M, Bodnar RJ. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats. Brain Res 2000; 876: 76-87.
34. Znamensky V, Echo JA, Lamonte N, Christian G, Ragnauth A, Bodnar RJ. gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats. Brain Res 2001; 906: 84-91.
35. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates 2nd edn Academic Press: San Diego, 1986.
36. Nicholson C. Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 1985; 333: 325-329.
37. Martin WR, Wikler A, Eades CG, Pescor FT. Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 1963; 4: 247-260.
38. South T, Deng C, Huang XF. AM 251 and beta-funaltrexamine reduce fat intake in a fat-preferring strain of mouse. Behav Brain Res 2007; 181: 153-157.
39. Holtzman SG. Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J Pharmacol Exp Ther 1974; 189: 51-60.
40. Bodnar RJ. Endogenous opiates and behavior: 2006. Peptides 2007; 28: 2435-2513.
41. Statnick MA, Tinsley FC, Eastwood BJ, Suter TM, Mitch CH, Heiman ML. Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization. Am J Physiol Regul Integr Comp Physiol 2003; 284: R1399-R1408.
42. Kotz CM, Billington CJ, Levine AS. Opioids in the nucleus of the solitary tract are involved in feeding in the rat. Am J Physiol 1997; 272: R1028-R1032.
43. Wilson JD, Nicklous DM, Aloyo VJ, Simansky KJ. An orexigenic role for mu-opioid receptors in the lateral parabrachial nucleus. Am J Physiol Regul Integr Comp Physiol 2003; 285: R1055-R1065.
44. Vaccarino FJ, Taube MR. Intra-arcuate opiate actions stimulate GRF-dependent and protein-selective feeding. Peptides 1997; 18: 197-205.
45. Figlewicz DP, Bennett JL, Aliakbari S, Zavosh A, Sipols AJ. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am J Physiol Regul Integr Comp Physiol 2008; 295: R388-R394.
46. McLean S, Hoebel BG. Feeding induced by opiates injected into the paraventricular hypothalamus. Peptides 1983; 4: 287-292.
47. Mucha RF, Iversen SD. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res 1986; 397: 214-224.
48. MacDonald AF, Billington CJ, Levine AS. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am J Physiol Regul Integr Comp Physiol 2003; 285: R999-R1004.
49. Tabarin A, Diz-Chaves Y, Carmona Mdel C, Catargi B, Zorrilla EP, Roberts AJ et al. Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a 'thrifty gene'. Diabetes 2005; 54: 3510-3516.
50. Zuberi AR, Townsend L, Patterson L, Zheng H, Berthoud HR. Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice. Eur J Pharmacol 2008; 585: 14-23.
51. Zhang M, Kelley AE. Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats. Psychopharmacology (Berl) 1997; 132: 350-360.
52. Levine AS, Billington CJ. Opioids as agents of reward-related feeding: a consideration of the evidence. Physiol Behav 2004; 82: 57-61.
53. Leventhal L, Cole JL, Bodnar RJ. Reductions in locomotor activity following central opioid receptor subtype antagonists in rats. Physiol Behav 1996; 60: 833-836.
54. Levin BE, Keesey RE. Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol 1998; 274: R412-R419.
55. Zhang M, Kelley AE. Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and fos expression. Neuroscience 2000; 99: 267-277.
56. Pecina S, Berridge KC. Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? J Neurosci 2005; 25: 11777-11786.